ProCE Banner Activity

Epigenetic Therapy in Indolent B-Cell Lymphomas: A Summary Resource

PDF
Download this online resource developed to serve as a helpful guide for healthcare professionals on tazemetostat and investigational epigenetic therapies in indolent B-cell lymphomas.

Released: April 28, 2022

Expiration: April 27, 2023

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Bristol Myers Squibb

Incyte Corporation